Breast cancer is among the most dreadful malignancies in women causing the highest
mortality across the globe. The prevalent therapies have not been able to be efficacious to …

As a drug delivery system with wide application potential, serum albumin drug‐carrying
nanoparticles have attracted extensive attention in the field of drug delivery in recent years …

Curcumin (Cur), a naturally occurring bioactive compound belonging to the polyphenol class
is loaded with a variety of medicinal properties. Its poor bioavailability and suboptimal …

Human serum albumin (HSA) as a drug carrier can significantly improve the
pharmacokinetic profiles of short-lived therapeutics. Conjugation of albumin-binding …

Immunotherapy has captured attention for its high clinical efficacy. However, its efficacy is
limited by inadequate immune activation. Therefore, a platform to activate the immune …

Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast
cancer still lacking effective treatment options. Chemotherapy in combination with …

Aims: Preparation and evaluation of nanoparticles for tumor chemotherapy and
immunotherapy mild photothermal therapy and oxaliplatin. Methods: The double emulsion …

BACKGROUND Human serum albumin (HSA) is the most abundant protein in plasma,
playing crucial roles in regulating osmotic pressure and maintaining protein homeostasis. It …

Small molecule fluorophores often face challenges such as short blood half-life, limited
physicochemical and optical stability, and poor pharmacokinetics. To overcome these …

Human serum albumin (HSA), a polypeptide featuring 17 disulfide bonds, acts as a crucial
transport protein in human blood plasma. Its extended circulation half-life, mediated by FcRn …